One in five people with cancer who were employed full-time at the time of diagnosis felt their employer could do more to understand their needs, research has found.
"One size does not fit all" when it comes to purchasing products for employee cancer cover, according to Jelf Employee Benefits.
International health insurers are not being clear enough in explaining to planholders exactly what treatments they will cover, international PMI provider InterGlobal has said.
More people are being diagnosed with and dying from kidney cancer in England today, compared to 10 years ago according to new figures released.
Cancer is costing countries across the European Union an estimated €126 billion in costs including healthcare and productivity losses, research has revealed.
Macmillan has warned the Cancer Drugs Fund is not secure for the long term.
The cost of caring for inpatients with breast and prostate cancer in England will surge by a 20% in a decade, hitting at least £790million a year by 2020.
CIExpert has positively reviewed Scottish Provident's three new alterations to its Self Assurance critical illness (CI) policy which take effect from 16th September.
Death rates from malignant melanoma are 70% higher in men than women, despite similar numbers being diagnosed with the disease each year, according to the latest figures from Cancer Research UK.
Cancer Research UK has unveiled a new website revealing a comprehensive breakdown of cancer statistics, which allows everyone to get the latest figures for their area.